- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-0646
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Extrahepatic metabolism of ibrutinib ; day:4 ; month:7 ; year:2020 ; pages:1-14
Investigational new drugs ; (4.7.2020), 1-14
- Urheber
-
Rood, Johannes J. M.
Jamalpoor, Amer
Hoppe, Stephanie van
Haren, Matthijs J. van
Wasmann, Roeland E.
Janssen, Manoe J.
Schinkel, Alfred H.
Masereeuw, Rosalinde
Beijnen, Jos H.
Sparidans, Rolf W.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10637-020-00970-x
- URN
-
urn:nbn:de:101:1-2020090421555594660292
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rood, Johannes J. M.
- Jamalpoor, Amer
- Hoppe, Stephanie van
- Haren, Matthijs J. van
- Wasmann, Roeland E.
- Janssen, Manoe J.
- Schinkel, Alfred H.
- Masereeuw, Rosalinde
- Beijnen, Jos H.
- Sparidans, Rolf W.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Extrahepatic drug metabolism and chemical carcinogenesis : proceedings of the International Meeting on Extrahepatic Drug Metabolism and Chemical Carcinogenesis, held in Stockholm, Sweden, on 17 - 20 May, 1983
Drug Review: Ibrutinib
Ibrutinib/Rituximab oder Ibrutinib allein – es kommt darauf an : Chronische lymphatische Leukämie
Resection of extrahepatic bile ducts with partial hepatectomy for treating intra- and extrahepatic hepatolithiasis
Ibrutinib for B cell malignancies
Ibrutinib: Nutzenbewertung gemäß § 35a SGB V
Ibrutinib dose modifications in the management of CLL
Multistage closure of a congenital extrahepatic portosystemic shunt
Advanced ultrasound diagnosis of extrahepatic bile duct lesions
Percutaneous Transhepatic Biopsy for Extrahepatic Lesions
Ibrutinib and the chemotactic lymph node choreography
Repurposing of Ibrutinib and Quizartinib as potent inhibitors of necroptosis
Extrahepatic drug metabolism and chemical carcinogenesis : proceedings of the International Meeting on Extrahepatic Drug Metabolism and Chemical Carcinogenesis, held in Stockholm, Sweden, on 17 - 20 May, 1983
Drug Review: Ibrutinib
Ibrutinib/Rituximab oder Ibrutinib allein – es kommt darauf an : Chronische lymphatische Leukämie
Resection of extrahepatic bile ducts with partial hepatectomy for treating intra- and extrahepatic hepatolithiasis
Ibrutinib for B cell malignancies
Ibrutinib: Nutzenbewertung gemäß § 35a SGB V
Ibrutinib dose modifications in the management of CLL
Multistage closure of a congenital extrahepatic portosystemic shunt
Advanced ultrasound diagnosis of extrahepatic bile duct lesions
Percutaneous Transhepatic Biopsy for Extrahepatic Lesions
Ibrutinib and the chemotactic lymph node choreography
Repurposing of Ibrutinib and Quizartinib as potent inhibitors of necroptosis
Extrahepatic drug metabolism and chemical carcinogenesis : proceedings of the International Meeting on Extrahepatic Drug Metabolism and Chemical Carcinogenesis, held in Stockholm, Sweden, on 17 - 20 May, 1983
Drug Review: Ibrutinib
Ibrutinib/Rituximab oder Ibrutinib allein – es kommt darauf an : Chronische lymphatische Leukämie
Resection of extrahepatic bile ducts with partial hepatectomy for treating intra- and extrahepatic hepatolithiasis
Ibrutinib for B cell malignancies
Ibrutinib: Nutzenbewertung gemäß § 35a SGB V
Ibrutinib dose modifications in the management of CLL
Multistage closure of a congenital extrahepatic portosystemic shunt
Advanced ultrasound diagnosis of extrahepatic bile duct lesions
Percutaneous Transhepatic Biopsy for Extrahepatic Lesions
Ibrutinib and the chemotactic lymph node choreography